Athena Technology Acquisition Corp. (NYSE:ATHN) announced in a press release today that its shareholders have approved its combination with solar energy provider Heliogen.
Over 91% of the votes cast at today’s special meeting were in favor of the approval of the business combination. ATHN stockholders also voted to approve all other proposals that were on the ballot.
The press release did not disclose redemption figures, but on the day of its December 23 redemption deadline, ATHN, which has an estimated trust value of $10.00, traded above its trust value and hit a high of $10.21 today.
The parties expect to close the transaction on Thursday, December 30, 2021. Following the closing, the combined company will be renamed “Heliogen, Inc.” and its common stock and warrants are expected to commence trading on the New York Stock Exchange under the symbols “HLGN” and “HLGNW,” respectively, on Friday, December 31, 2021.
Athena Tech and Heliogen initially announced their $2 billion combination on July 7. The Pasadena, California-based company aims to launch solar power plant design that provides flat, continuous power throughout the day.
ADVISORS
- Cohen & Company Capital Markets (a division of J.V.B. Financial Group, LLC), is serving as financial advisor to Athena.
- Barclays is serving as financial advisor to Heliogen.
- Cohen & Company Capital Markets is also serving as placement agent to Athena.
- DLA Piper LLP (US) is serving as legal advisor to Athena.
- Cooley LLP is acting as legal advisor to Heliogen.


Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 27, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...
Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...
CEO Marc Nemati and Colombier II’s Omeed Malik break down the deal and the strategy. Despite its moniker as the “the everything store” you can’t buy everything on Amazon, and firearms are one of those things. But, GrabAGun has spent years building a platform for regulated online firearms purchases, and soon, consumers will be able...
At the SPAC of Dawn Futures remain green after Fed Chairman Jerome Powell hinted at a July rate cut and tensions cooled for now in the Middle East. That has not warmed all corners of the SPAC market as teams continue to hit bumps in their shareholder votes this week. Four Leaf (NASDAQ:FORL) was the...
Lightwave Acquisition Corp. (NASDAQ:LWACU) announced the pricing of its $187.5 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LWACU”, Wednesday, June 25, 2025. The new SPAC plans to combine with a technology target or another industry that complements its management team’s background. Lightwave’s management team is led...